Nuzenio

Targeted Oncology Fda

Targeted Oncology Fda entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 10 latest news signals 1 publisher sources 100/100 entity strength

Latest news

BI-1808 Receives FDA Fast Track Designation in Ovarian Cancer - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 20:14:04 GMT FDA Clears Bria-PROS+ Immunotherapy Trial in Prostate Cancer - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 00:45:35 GMT FDA Grants Accelerated Approval to RP1 Plus Nivolumab in Advanced Melanoma - Targeted OncologyTargeted Oncology · Thu, 06 Aug 2026 20:57:12 GMT Reacting to the FDA Advisory Committee Verdict on RP1 in Melanoma - Targeted OncologyTargeted Oncology · Wed, 05 Aug 2026 19:00:00 GMT Lurbinectedin Second-Line SCLC Indication to Be Withdrawn After LAGOON - Targeted OncologyTargeted Oncology · Wed, 05 Aug 2026 14:09:27 GMT FDA Grants Tentative Approval to New Cabozantinib Capsule Formulation - Targeted OncologyTargeted Oncology · Tue, 04 Aug 2026 05:35:23 GMT FDA Grants Breakthrough Status to Olomorasib in Pancreatic Cancer - Targeted OncologyTargeted Oncology · Mon, 03 Aug 2026 20:07:34 GMT Menin Inhibitor Enzomenib Gains FDA Orphan Drug Designation in ALL - Targeted OncologyTargeted Oncology · Fri, 31 Jul 2026 19:06:27 GMT

Timeline

Fri, 07 Aug 2026 20:14:04 GMTBI-1808 Receives FDA Fast Track Designation in Ovarian Cancer - Targeted Oncology

Fri, 07 Aug 2026 00:45:35 GMTFDA Clears Bria-PROS+ Immunotherapy Trial in Prostate Cancer - Targeted Oncology

Thu, 06 Aug 2026 20:57:12 GMTFDA Grants Accelerated Approval to RP1 Plus Nivolumab in Advanced Melanoma - Targeted Oncology

Wed, 05 Aug 2026 19:00:00 GMTReacting to the FDA Advisory Committee Verdict on RP1 in Melanoma - Targeted Oncology

Wed, 05 Aug 2026 14:09:27 GMTLurbinectedin Second-Line SCLC Indication to Be Withdrawn After LAGOON - Targeted Oncology

Tue, 04 Aug 2026 05:35:23 GMTFDA Grants Tentative Approval to New Cabozantinib Capsule Formulation - Targeted Oncology

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

Oncology Targeted Oncology6 live mentions Targeted Oncology4 live mentions Track Designation3 live mentions Receives FDA Fast2 live mentions PROS2 live mentions Immunotherapy Trial2 live mentions Approval2 live mentions Plus Nivolumab2 live mentions FDA Advisory Committee2 live mentions Verdict2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Targeted Oncology Fda.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.